A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing. [electronic resource]
- Applied health economics and health policy Feb 2013
- 79-82 p. digital
Publication Type: Letter; Comment
1179-1896
10.1007/s40258-012-0008-7 doi
Drug Costs--standards Drug Industry--economics Economics, Pharmaceutical Humans Reimbursement, Incentive--economics